Resultados: 48

    WHO Guidelines for pharmacological management of pandemic Influenza A(H1N1) 2009 and other influenza viruses: part I recommendations

    The purpose of this document is to provide a basis for advice to clinicians on the use of the currently available antivirals for patients presenting with illness due to influenza virus infection, as well their use for chemoprophylaxis. This guidance updates and replaces the recommendations published in A...

    WHO Guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses: part II review of evidence

    This revised guidance is published in two parts. Part II documents the procedures followed in developing this guidance, together with a review of evidence and other new information on the pharmacological agents considered....

    Response to measles outbreaks in measles mortality reduction settings

    The guidance provided in this document is intended to encourage the principles of early detection of measles outbreaks, thorough assessment, and a rapid response that includes expanded use of measles vaccine. The nature and extent of the vaccination response should be based on an assessment of risk of sp...

    Pandemic influenza preparedness and response: a WHO guidance document

    This guidance is an update of WHO global influenza preparedness plan, the role of WHO and recommendations for national measures before and during pandemics, published by WHO in March 2005. The information and recommendations contained in this guidance document are the product of expert. In light of these...

    Dengue: guidelines for diagnosis, treatment, prevention and control

    Dengue is the most rapidly spreading mosquito-borne viral disease in the world. In the last 50 years, incidence has increased 30-fold with increasing geographic expansion to new countries and, in the present decade, from urban to rural settings. This publication is intended to contribute to prevention an...

    Manual for the health care of children in humanitarian emergencies

    The objective of this manual is to provide comprehensive guidance on child care in emergencies. Existing guidelines, such as Integrated Management of Childhood Illness IMCI, assume a functioning health system that facilitates the referral of children, which may not be available in emergency situations. S...

    Reducing excess mortality from common illnesses during an influenza pandemic WHO guidelines for emergency health interventions in community settings

    Communicable diseases are currently the leading cause of preventable deaths worldwide, disproportionately affecting resource-poor settings. Pandemic influenza would add to already unacceptable levels of morbidity and mortality from diarrhoea, malaria, pneumonia, malnutrition, HIV/AIDS and tuberculosis, i...

    ACIP evidence to recommendations for use of moderna COVID-19 vaccine in children ages 6 months – 5 years and Pfizer-BioNTech COVID-19 vaccine in children ages 6 months – 4 years under an Emergency use authorization

    he emergence of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), has led to a global pandemic with substantial societal and economic impacts on individual persons and communities. In the United States, more than 85 million cases and more than 1,000,000 COVID-19-associated deaths hav...